Biotechnology Jobs

• London
• Hybrid · 2 days in office
• US$340,500 – US$567,500 pa
• Senior · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability and chairing a cross-functional matrix Medicine Development Team spanning clinical, translational, regulatory, manufacturing and commercial. Drives strategy, go/no-go decisions and lifecycle plans for novel vaccine platforms such as mRNA and neoantigen-based therapies.

mRNA · Checkpoint Inhibitors

• Waltham, United States
• Hybrid · 2 days in office
• US$340,500 – US$567,500 pa
• Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.

mRNA · Personalized Vaccine Manufacturing · Checkpoint Inhibitors

• Waltham, United States
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical/QC testing network strategy across GSK's global supply chain, translating approved strategy into operational roadmaps and securing governance endorsement. Partners with Quality, MSAT, R&D and product leads on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting and risk mitigation for large molecules, ADCs and Oligos.

• London
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Benchmarks industry practice and builds KPI reporting and capability within the GSC Strategy team.

• Zebulon, United States
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical/QC testing network strategy across the global supply chain, translating approved strategy into an operational roadmap and securing endorsement from governance forums such as the Supply Chain Review Board. Partners with GSC Quality, MSAT and R&D on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting for senior leadership. Focuses on analytical testing strategy for large molecules, ADCs and Oligos.

• Upper Merion
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Collaborates with GSC Quality, MSAT and R&D, benchmarks industry best practice, and establishes KPIs and reporting for senior leadership. Focuses on analytical testing strategy for large molecules, ADCs and Oligos.

• Belgium-Wavre
• €148,500 – €247,500 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's global supply chain, defining QC testing network principles and translating them into an operational roadmap. Acts as the single point of contact in GSC Strategy, collaborating with Quality, MSAT and R&D, benchmarking industry practice and reporting KPIs to senior leadership.

• Philadelphia, United States
• US$203,775 – US$339,625 pa
• Director

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing, leading US post-marketing vaccine effectiveness studies and external academic and data-partner collaborations. Requires deep expertise in influenza epidemiology, real-world data and causal methods, plus influence across a global matrix.

Medicare · EHR

• Waltham, United States
• US$203,775 – US$339,625 pa
• Director

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing, leading US post-marketing vaccine effectiveness studies and complex external collaborations with academic and healthcare data partners.

Medicare · EHR · Administrative Claims +1

• London
• US$203,775 – US$339,625 pa
• Director

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing phases, leading US post-marketing vaccine effectiveness studies and complex external collaborations with academic and healthcare data partners.

Medicare · EHR · Administrative Claims +1

• Durham, United States
• US$203,775 – US$339,625 pa
• Director

Leads the integrated real-world evidence and health outcomes strategy for mRNA influenza vaccines, designing and interpreting US post-marketing vaccine effectiveness studies across late-stage development, launch and post-marketing phases. Partners with clinical development, epidemiology, medical affairs, regulatory, biostatistics and market access teams, and builds collaborations with academic investigators, healthcare systems and data partners. Requires deep expertise in US vaccine effectiveness research, influenza epidemiology, real-world data and causal methods.

Medicare · EHR · Administrative Claims +1

• USA - Pennsylvania - Upper Providence
• US$203,775 – US$339,625 pa
• Director

Provides scientific and strategic leadership for real-world evidence supporting GSK's mRNA vaccine portfolio, with a primary focus on influenza. Leads post-marketing vaccine effectiveness studies in the US, translating evidence needs into rigorous study designs and building collaborations with academic investigators, healthcare systems and data partners. Requires deep expertise in US vaccine effectiveness research, influenza epidemiology, real-world data and causal methods.

Medicare · EHR

• Waltham, United States
• US$195,525 – US$325,875 pa
• Director

Senior individual contributor shaping GSK's Enterprise AI opportunity portfolio across market research, competitive intelligence and knowledge graphs, deciding where forward-deployed engineering pods focus. Involves hands-on prototyping with LLMs and agentic systems, building business cases, defining success metrics and running executive conversations to fund and scale AI products.

IQVIA · Komodo · Reltio +5

• London
• Mid-level

Mid-level individual contributor on GSK's Enterprise AI Forward Deployed Engineering team, embedded with business unit teams to prototype AI proofs of concept at a days-to-weeks cadence. Works under senior FDEs using AI coding assistants and multi-agent workflows as the default mode of building, then hands proven solutions off cleanly for productionisation.

Claude Code · GitHub Copilot · Databricks AI Assistant +3

• Philadelphia Walnut Street
• US$95,700 – US$159,500 pa
• Mid-level

Mid-level individual contributor on GSK's Enterprise AI Forward Deployed Engineering team, embedded with business unit teams to prototype AI proofs of concept at a days-to-weeks cadence. Works under senior FDEs using AI coding assistants and multi-agent workflows as the default mode of building, then hands proven solutions off cleanly to Solutions Engineers for productionisation.

Claude Code · GitHub Copilot · Databricks AI Assistant +3